| The difference between a dynamic and mechanical approach to stroke treatment. | |
| | |
MedLine Citation:
|
PMID: 17601385 Owner: NLM Status: In-Data-Review |
Abstract/OtherAbstract:
|
The current classification of stroke is based on causation, also called pathogenesis, and relies on binary logic faithful to the Aristotelian tradition. Accordingly, a pathology is or is not the cause of the stroke, is considered independent of others, and is the target for treatment. It is the subject for large double-blind randomized clinical therapeutic trials. The scientific view behind clinical trials is the fundamental concept that information is statistical, and causation is determined by probabilities. Therefore, the cause and effect relation will be determined by probability-theory-based statistics. This is the basis of evidence-based medicine, which calls for the results of such trials to be the basis for physician decisions regarding diagnosis and treatment. However, there are problems with the methodology behind evidence-based medicine. Calculations using probability-theory-based statistics regarding cause and effect are performed within an automatic system where there are known inputs and outputs. This method of research provides a framework of certainty with no surprise elements or outcomes. However, it is not a system or method that will come up with previously unknown variables, concepts, or universal principles; it is not a method that will give a new outcome; and it is not a method that allows for creativity, expertise, or new insight for problem solving. |
| | |
Authors:
|
Cathy M Helgason |
Related Documents
:
|
4019705 - Determining the duration of comparative clinical trials while allowing for cure. 10471225 - On the scientific inference from clinical trials. 3838715 - A fortran program for the design and analysis of sequential clinical trials. 17590875 - Bayesian predictive power for interim adaptation in seamless phase ii/iii trials where ... 17266115 - A partially linear tree-based regression model for assessing complex joint gene-gene an... 11300625 - Experimental design of an optimal phase duration control strategy used in batch biologi... |
Publication Detail:
|
Type: Journal Article |
Journal Detail:
|
Title: Current treatment options in cardiovascular medicine Volume: 9 ISSN: 1092-8464 ISO Abbreviation: Curr Treat Options Cardiovasc Med Publication Date: 2007 Jun |
Date Detail:
|
Created Date: 2007-07-02 Completed Date: - Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 9815942 Medline TA: Curr Treat Options Cardiovasc Med Country: United States |
Other Details:
|
Languages: eng Pagination: 213-20 Citation Subset: - |
Affiliation:
|
Cathy M. Helgason, MD University of Illinois at Chicago, Neurology and Rehabilitation, MC796, 912 South Wood Street, Room 855N, Chicago, IL 60612, USA. helgason@uic.edu. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
|
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: The role of angiogenesis in damage and recovery from ischemic stroke.
Next Document: The nature of hand motor impairment after stroke and its treatment.